A prospective study of DMAIC-based six sigma implementation for analytical quality improvement in a clinical biochemistry laboratory
Bioinformation · 31.10.2026 · 22 (10) · 7069-7076
DOI: 10.6026/973206300227069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.10.2026. Verfasst von Mrityunjoy Halder.
Abstract (Originalsprache)
Analytical errors in clinical biochemistry can compromise patient safety and clinical decision-making. Therefore, it is of interest to evaluate a DMAIC-based quality improvement programme for 20 serum chemistry analytes over 11 months. Baseline and endpoint data were compared using CLIA 2025 allowable total error, IQC-derived coefficient of variation, EQA-derived bias and Quality Goal Index analysis. Unacceptable analytes decreased from 11 to 2, while world-class and excellent performers increased from 0 to 4 and 0 to 3, respectively. Thus, data shows the DMAIC-based Six Sigma programme improved analytical performance and supported risk-based quality control planning for sustainable laboratory quality improvement.
Zitieren
APA
Halder, M. (2026). A prospective study of DMAIC-based six sigma implementation for analytical quality improvement in a clinical biochemistry laboratory. Bioinformation, 22(10), 7069-7076. https://doi.org/10.6026/973206300227069
Vancouver
Halder M. A prospective study of DMAIC-based six sigma implementation for analytical quality improvement in a clinical biochemistry laboratory. Bioinformation. 2026;22(10):7069-7076. doi:10.6026/973206300227069
BibTeX
@article{Halder2026,
author = {Halder, Mrityunjoy},
title = {A prospective study of DMAIC-based six sigma implementation for analytical quality improvement in a clinical biochemistry laboratory},
journal = {Bioinformation},
year = {2026},
volume = {22},
number = {10},
pages = {7069--7076},
doi = {10.6026/973206300227069}
}
EUVIMED